Answering your questions about wellness exams for adults assigned female at birth – often called the “well woman exam”

November 1, 2025

Adults of reproductive age (18-45 years) who were assigned female at birth (i.e., born with a vulva and a vagina) frequently ask what screening examinations and tests are recommended for maintaining optimal health. Regular wellness visits are recommended for all adults to discuss reproductive life planning and to screen for common conditions like obesity, hypertension, depression, intimate partner violence, and substance abuse. However, physical examinations and diagnostic tests may be needed less often. (Additional recommendations for adolescents should be followed as indicated.)

Dr. Carrie Cwiak, Professor of Gynecology and Obstetrics at Emory University, offers the following answers to frequently asked questions:

Questions

How often should I have cervical cancer screening?

Cervical cancer screening is most commonly performed with a Pap test, which tests if the cells on your cervix show any signs of precancerous changes. This test is first done when you turn 21 years of age. After a normal result, a Pap test should be repeated every 3 years. If you have an abnormal result, you may need a repeat Pap test in 1 year or a test called a colposcopy (an examination that looks at your cervix with a microscope to look for abnormal cells and to determine if a biopsy needs to be taken).

Starting when you reach age 25, a human papillomavirus (HPV) test is often added to abnormal Pap tests to determine if a colposcopy is needed. Starting when you reach age 30, co-testing (Pap and HPV testing) is recommended. If both Pap and HPV test results are negative, then co-testing should be repeated every 5 years.

Future screening recommendations will include the option for HPV testing as a stand-alone test without requiring a Pap test.

How often should I be tested for sexually transmitted infections?

Every adult should have a blood test for human immunodeficiency virus (HIV) and hepatitis C at least once in their lifetime.

Testing for chlamydia and gonorrhea is recommended annually until you are age 25 and then regularly whenever you have a new partner, or if your partner may have a new partner, or if you have symptoms suggestive of infection. This can be done with a self-swab, blind swab (i.e., no speculum used), or a pelvic examination using a speculum.

Testing for syphilis (blood test) and trichomonas (swab) are recommended for people with suggestive symptoms and in areas that have a high incidence of those infections. People unvaccinated for hepatitis B should have testing for infection and receive a vaccination if found to not be immune.

How often should I have a pelvic examination?

A pelvic examination should be done whenever you have questions about your genital development or concerning symptoms (e.g., lesions, itching, odor, discharge, pain, abnormal bleeding). It is performed when a provider places a speculum in your vagina to see your vagina and cervix, and/or places their fingers in your vagina to feel your cervix, uterus, and ovaries. If testing for infection, pap, or HPV is also needed, they can complete this at the same time. A Pap test or other test for infection is not always performed during a pelvic examination – patients should ask their provider what testing is done if they undergo a pelvic examination.

How often should I have a breast examination?

A breast examination should be done whenever you have questions about your breast development or concerning symptoms (nipple discharge, skin changes, pain, or a persistent mass). For people who have a personal or family history of a BRCA mutation, annual breast examinations should begin at age 25. Otherwise, breast examination may be done every 1-3 years, beginning when you reach age 25.

Depending on the health organization, a mammogram is recommended either every 1 or 2 years beginning when you reach age 40. Since a mammogram is currently the best method of screening for breast cancer, it is reasonable to have a screening mammogram and breast examination beginning when you reach age 40.

Are there other blood tests that are recommended?

If you have concerning symptoms, a positive family history, or other risk factors for anemia (e.g. heavy menstrual bleeding), thyroid disease (irregular menstrual bleeding), diabetes (obesity), or elevated cholesterol (obesity), regular blood testing is recommended.

What vaccinations are recommended?

If you have received all recommended vaccines in childhood, then there are fewer vaccines you will need as an adult:

  • HPV vaccination is recommended for all people of any gender to prevent HPV-related diseases like genital warts, cervical cancer, anal cancer, and throat cancer. It can be given to children as early as age 9. If you receive your first dose before age 15, then you only need one more dose 6 months later. Otherwise, a total of 3 doses is needed: at day 1, at 1-2 months, and at 6 months. A booster dose is not needed.
  • Influenza vaccinations are recommended annually during influenza season (fall to winter).

Are there other cancer screening tests recommended?

Screening for colon cancer by colonoscopy is recommended starting when adults reach age 45. People at higher risk for colon cancer (due to family history, etc.) may need to begin screening at an earlier age.

Additional screening tests may be recommended for patients with suggestive symptoms or risk factors for particular conditions.


Reference

2024 Recommendations for Women’s Preventive Health Care. Women’s Preventive Services Initiative (WPSI). ACOG Foundation. 2024. Supported by: American Academy of Family Physicians, American College of Obstetricians and Gynecologists (ACOG), American Academy of Physicians, and the National Association of Nurse Practitioners in Women’s Health.

Other Latebreakers

Nov. 01, 2025

Answering your questions about wellness exams for adults assigned female at birth – often called the “well woman exam”

Sep. 05, 2025

Acute Heavy Menstrual Bleeding!

Aug. 01, 2025

New and Updated Guidelines for Cervical Cancer Screening

Jun. 20, 2025

The Patient Asks—I’m on Depo-Provera, What’s My Risk for Meningioma?

May. 01, 2025

Clinical Tools for Contraceptive Eligibility and Practice

Jan. 13, 2025

New ovarian cyst despite CHC use by patient with PCOs?

Nov. 14, 2024

Mood Swings, Depression, and CHCs

Oct. 15, 2024

Higher Body Weight Effect on Combined Hormonal Contraceptives

Sep. 09, 2024

Perimenopause: pregnancy risks

Aug. 13, 2024

NEW! 2024 MEC & SPR (Free from the CDC)

Jul. 19, 2024

Medication Interactions and Contraceptive Effectiveness

Jun. 05, 2024

“Birth control has a TikTok problem.”

May. 08, 2024

Implant: Unpredictable Bleeding and Management

Mar. 19, 2024

Weight Changes and hormonal contraceptives

Feb. 16, 2024

What most affects contraceptive continuation?

Jan. 03, 2024

Resuming CT monthly updates! Introducing the new edition of Contraceptive Technology

Dec. 20, 2021

Substance use disorder: contraceptive options counseling

Oct. 15, 2021

What’s New in Contraception?

Sep. 21, 2021

Contraceptive Technology Conference!

Aug. 25, 2021

Biologic sexism of STIs

Jul. 16, 2021

Excess breast cancer deaths after COVID-19

Jul. 04, 2021

Contraception for patients with medical conditions

May. 18, 2021

Pelvic Floor Dysfunction

Mar. 04, 2021

Treating vulvodynia

Feb. 11, 2021

Puzzling Over the Hurt Down-Under

Jan. 06, 2021

Serious Mental Illness and Contraception

Oct. 28, 2020

New 13-Cycle Vaginal Contraceptive System

Oct. 08, 2020

The Future of Family Planning in Post-COVID America

Sep. 09, 2020

New ASCCP Guidelines: Implications for FP

Aug. 02, 2020

On the alert: mood disorders during 2020 stressors

Jun. 25, 2020

Sex in the Time of COVID-19

May. 08, 2020

Challenges old and new during the pandemic

Mar. 31, 2020

Reproductive health in the time of Covid-19

Mar. 09, 2020

Talking about toys

Feb. 10, 2020

Missed Pills: The Problem That Hasn’t Gone Away

Jan. 02, 2020

Find the “yes! . . . and” rather than “no” or “but”

Nov. 01, 2019

Digital Family Planning: the Future is Now

Oct. 08, 2019

Irregular Bleeding Due to Contraceptives

Sep. 06, 2019

When she’s low on libido…

Aug. 06, 2019

Ouch! Best approaches to menstrual pain

Jun. 27, 2019

Contraceptive efficacy: understanding how user and method characteristics play their part

May. 29, 2019

Strategizing treatment for chronic heavy menstrual bleeding

May. 10, 2019

Perimenopause

Mar. 27, 2019

Untangling the literature on obesity and contraception

Feb. 26, 2019

High tech apps for no-tech FABM

Jan. 25, 2019

Menstrual exacerbation of other medical conditions

Jan. 04, 2019

From Princeton University: Thomas James Trussell (1949-2018)

Nov. 30, 2018

The Short and Long of IUD Use Duration

Oct. 30, 2018

Selecting a Method When Guidance Isn’t Clear-cut

Oct. 04, 2018

Healthcare in the Time of Digital Expansion

Aug. 30, 2018

Combined pills’ effect on mood disorders

Aug. 30, 2018

The Scoop on Two New FDA-Approved Contraceptive Methods

Aug. 01, 2018

Pregnancy of unknown location—meeting the challenge

Jul. 03, 2018

Big “yes” (with caveats) to CHCs during perimenopause

Apr. 02, 2018

Abortion in the U.S.: safe, declining, and under threat

Feb. 02, 2018

Hope for ovarian cancer screening test

Jan. 03, 2018

Breast cancer still a small risk with some hormonal contraceptives

Dec. 04, 2017

New treatment modality for BV

Nov. 07, 2017

Record rate of HPV-related throat cancer

Oct. 03, 2017

Viruses in semen potentially transmissible

Sep. 01, 2017

Don’t Abstain from Your Role in Abstinence

Jul. 26, 2017

Teens births declining but geographic ‘hotspots’ defy trend

Jun. 27, 2017

Online Medical Abortion Service Effective and Safe

May. 30, 2017

Do Women Really Need to Wait That Long?

May. 05, 2017

Reassuring news on depression and OC use

Apr. 06, 2017

PMDD: Genetic clues may lead to improved treatment

Mar. 02, 2017

Breast cancer risk when there is a family history

Feb. 03, 2017

Body weight link to breast and endometrial cancers (and 11 others)

Jan. 03, 2017

Family Planning in 2017 and Beyond

Dec. 01, 2016

Make Me Cry: Depression Link (Again)?

Nov. 02, 2016

Managing implant users’ bleeding and spotting

Oct. 13, 2016

Zika: Updated guidance for providers

Sep. 06, 2016

Pharmacist-prescribed contraceptives

Aug. 01, 2016

Hot off the press! 2016 MEC and SPR

Jul. 05, 2016

Zika virus fears prompt increased request for abortion in nations outlawing abortions

Jun. 13, 2016

Opioid use epidemic among reproductive-age women

May. 04, 2016

Good news on the family planning home front!

Apr. 04, 2016

War Against Planned Parenthood Hurts Women

Feb. 16, 2016

Win-win for both treatment and prevention

Feb. 08, 2016

Center of the Storm

Dec. 01, 2015

Ambivalence

Nov. 02, 2015

Menopause, mood, mental acuity, and hormone therapy

Oct. 01, 2015

Emergency contraception for teens

Sep. 03, 2015

Postpartum Contraception: Now, Not Later

Aug. 03, 2015

Reproductive tract infections, sexually transmitted infections, or sexually transmitted diseases: “a rose by any other name…”

Jun. 25, 2015

Are we practicing what we preach?

Jun. 02, 2015

Be alert to VTE in hormonal contraceptive users

May. 04, 2015

LARC among teens increased 15-fold, but not enough

Mar. 30, 2015

Brain cancer and hormonal contraception

Mar. 02, 2015

Free tools: Easy access to the US Medical Eligibility Criteria for Contraceptive Use

Feb. 02, 2015

Alcohol consumption when pregnancy is unwanted or unintended

Jan. 12, 2015

Latest Data on Contraceptive Use in the United States

Dec. 01, 2014

LateBreaker sampler from Contraceptive Technology conference

Nov. 05, 2014

Emergency Contraceptive Pill Efficacy and BMI/Body Weight

Sep. 29, 2014

Handout on Unintended Pregnancy and Contraceptive Choice

Aug. 27, 2014

Ask About Withdrawal (Really!)

Jul. 31, 2014

Rules to Practice By: Safety First and Cleanliness is Close to. . .

Jul. 01, 2014

What’s Vanity Fair Got Against the NuvaRing?

Jun. 02, 2014

Promising New Treatment for Hepatitis C

May. 01, 2014

Numbers matter, so make them simple for patients

Apr. 01, 2014

The Recession’s Effect on Unintended Pregnancies

Mar. 05, 2014

Lessons Learned from the Contraceptive CHOICE Project: The Hull LARC Initiative

Feb. 03, 2014

Applying the “New” Cervical Cytology Guidelines in Your Practice

Jan. 02, 2014

Acute Excessive Uterine Bleeding: New Management Strategies

Dec. 03, 2013

Medical indications for IUD use in teens

Oct. 09, 2013

Whatever happened to PID?

Oct. 05, 2013

Update on Emergency Contraception

Oct. 01, 2013

Contraceptivetechnology.com New and Improved